跳至主要内容
临床试验/JPRN-UMIN000029585
JPRN-UMIN000029585尚未招募2 期

Peranpanel and Levetiracetam vs Levetiracetam doze up Phase 2 study for brain tumor related epilepsy (Phase 2, PPAP study) - Peranpanel and Levetiracetam vs Levetiracetam doze up Phase 2 study for brain tumor related epilepsy (Phase 2, PPAP study)

Department of Neurosurgery, Hirosaki University Graduate School of Medicine0 个研究点目标入组 50 人开始时间: 2017年10月17日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16years-old 至 85years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Simultaneous or metachronous (within the past 5 years) double cancers, with the exception of intramucosal tumor curable with local therapy 2) Infection with systemic therapy indicated 3) fever over 38 degrees Celsius 4) Active infectious meningitis 5) Women during pregnancy, possible pregnancy or breast-feeding 6) Psychosis 7) Uncontrollable diabetes mellitus or administration of insulin 8) Unstable angina within 3 weeks, or with a history of myocardial infarction within 6 months 9) Interstitial pneumonia, or fibroid lung 10) Patients who can't receive gadolinium

研究者

发起方
Department of Neurosurgery, Hirosaki University Graduate School of Medicine

相似试验